Mounjaro®
Starting from £179.99/mo
Start journey Learn moreHair loss linked to semaglutide is real, but the biggest misconception is that the medicine itself is destroying your hair follicles. It isn't. The shedding most people notice during Wegovy treatment is typically a temporary, well-recognised response to rapid weight loss rather than a direct toxic effect of the drug — and for the vast majority it does reverse. That said, it deserves a straight answer, not reassurance that glosses over the detail. These are prescription-only medicines that require a clinical assessment before anyone starts them, and understanding the side-effect picture properly is part of making an informed decision about treatment.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
When people search for answers about semaglutide and hair loss, the fear is often that the medicine is causing permanent damage. The pharmacology doesn't support that. Semaglutide, the active ingredient in Wegovy, works by activating GLP-1 receptors that regulate appetite and slow gastric emptying, there is no established mechanism by which it directly harms hair follicles. What clinical trials and prescribers observe instead is a pattern called telogen effluvium: a temporary, diffuse shedding triggered by the physiological stress of rapid weight loss and significant calorie reduction.
In the STEP 1 trial, published in the New England Journal of Medicine, alopecia was reported as a side effect in a small proportion of participants on semaglutide 2.4mg. It appeared in a higher share of the active treatment group than placebo, which suggests the weight-loss process itself (not a coincidence) is the driver. The faster and more substantial the weight loss, the more likely the hair cycle is disrupted. That context changes the question: it isn't "is semaglutide poisoning my hair?" It's "how do I support my body through rapid change?"
Framing it accurately matters because it also tells you what to expect on the other side. Telogen effluvium is self-limiting. Once the acute stress phase passes and weight begins to stabilise, follicles re-enter their growth phase. Most people see the shedding peak around three to six months after it starts, with noticeable recovery following.
A question our prescribers hear most weeks is why one person on Wegovy barely notices any change in their hair while another loses significant volume. Several factors shape that difference, and most of them are modifiable.
Protein intake is the most consequential. Hair is predominantly keratin; when the body is in a calorie deficit and protein is scarce, it prioritises essential functions over hair production. Aiming for adequate daily protein (the exact target depends on your body weight and activity level, so your prescriber or a dietitian is the right person to advise) can meaningfully reduce the severity of shedding. Micronutrient deficiencies, particularly iron, zinc, biotin and vitamin D, are also associated with hair loss and can be worsened by restrictive eating. The NHS medicines information for semaglutide lists alopecia among the side effects reported during clinical trials.
The pace of weight loss is another factor outside anyone's full control but worth understanding. Faster initial loss, which is common at higher doses, correlates with more pronounced telogen effluvium. Slow titration (which is built into the Wegovy dosing schedule) offers some protection. If you want a closer look at how Wegovy side effects such as hair loss present and progress, that detail can help you recognise what is typical and what warrants further attention. You can also read more about the broader side-effect profile of Wegovy to get the full picture alongside hair-related concerns.
Stress, sleep, thyroid function and hormonal changes can all contribute independently. If shedding continues well after weight loss has levelled off, it's worth asking whether something else is running alongside the telogen effluvium rather than assuming the medicine is still responsible.
For most people, hair regrowth begins within six months of the shedding peak. Because telogen effluvium involves follicles shifting into a resting phase rather than being destroyed, the underlying architecture stays intact. New hairs emerge as the growth cycle restarts. The volume change can feel alarming in the moment (finding more hair in the shower than usual is genuinely distressing) but the underlying mechanism is benign and time-limited in the majority of cases.
There are situations, though, where you should seek medical advice rather than waiting it out. Get in touch with a prescriber or your GP if your hair loss is patchy rather than diffuse, if it is accelerating rather than plateauing, if it started before you began losing meaningful weight, or if it continues well beyond six months without any sign of recovery. These patterns may point to a separate condition (androgenetic alopecia, alopecia areata, thyroid dysfunction or iron-deficiency anaemia) that needs its own assessment.
If you experience any side effect you're concerned about, including hair loss, you can report it directly through the MHRA's Yellow Card scheme, which tracks adverse effects from medicines across the UK population. Reporting helps regulators build a clearer picture, even for effects that are already listed. For questions specific to your situation, our prescribers discuss side effects as part of every consultation, check your eligibility to start that conversation.
The broader context for anyone weighing this up: hair loss concerns about Wegovy are among the most common things people raise before starting treatment, and the honest answer is that a temporary shed is a real possibility, the permanent variety is not well-supported by the evidence, and good nutrition throughout treatment reduces the risk considerably. People who are still uncertain about whether semaglutide causes hair loss and want a deeper look at the evidence will find that page useful before making a decision. For those specifically looking into other Wegovy side effects such as evening nausea, the experience there follows a similar pattern, often most pronounced early in treatment, then easing.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.